HCV-IN-4

HCV-IN-4 is a potent, orally bioavailable NS5A inhibitor with pan-genotypic activity, demonstrating low picomolar to nanomolar EC90 values against HCV genotypes 1a, 2b, 3a, and key resistance mutants Y93H and L31V. This small molecule is a valuable research tool for investigating HCV replication mechanisms and evaluating antiviral efficacy in both cellular and animal model studies.